BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25017531)

  • 1. Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review.
    Banerji A; Lax T; Guyer A; Hurwitz S; Camargo CA; Long AA
    J Allergy Clin Immunol Pract; 2014; 2(4):428-33. PubMed ID: 25017531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
    Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
    J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.
    Wang AL; Patil SU; Long AA; Banerji A
    Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
    Feldweg AM; Lee CW; Matulonis UA; Castells M
    Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.
    Altwerger G; Gressel GM; English DP; Nelson WK; Carusillo N; Silasi DA; Azodi M; Santin A; Schwartz PE; Ratner ES
    Gynecol Oncol; 2017 Jan; 144(1):77-82. PubMed ID: 27789084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions.
    Vetter MH; Khan A; Backes FJ; Bixel K; Cohn DE; Copeland LJ; Fowler JM; Salani R; Li Q; O'Malley DM
    Gynecol Oncol; 2019 Feb; 152(2):316-321. PubMed ID: 30503265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
    Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC
    J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions.
    Otani IM; Lax T; Long AA; Slawski BR; Camargo CA; Banerji A
    J Allergy Clin Immunol Pract; 2018; 6(4):1266-1273.e2. PubMed ID: 28986119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study.
    Gomez R; Harter P; Lück HJ; Traut A; Kommoss S; Kandel M; du Bois A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1284-7. PubMed ID: 19823066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2005 Nov; 99(2):393-9. PubMed ID: 16054201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions.
    Patil SU; Long AA; Ling M; Wilson MT; Hesterberg P; Wong JT; Banerji A
    J Allergy Clin Immunol; 2012 Feb; 129(2):443-7. PubMed ID: 22099941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.
    Takase N; Matsumoto K; Onoe T; Kitao A; Tanioka M; Kikukawa Y; Yamaguchi S; Fujiwara K; Negoro S
    Int J Clin Oncol; 2015 Jun; 20(3):566-73. PubMed ID: 25030546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin.
    Bergamini A; Pisano C; Di Napoli M; Arenare L; Della Pepa C; Tambaro R; Facchini G; Gargiulo P; Rossetti S; Mangili G; Pignata S; Cecere SC
    Gynecol Oncol; 2017 Jan; 144(1):72-76. PubMed ID: 28094039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful re-treatment with taxol after major hypersensitivity reactions.
    Peereboom DM; Donehower RC; Eisenhauer EA; McGuire WP; Onetto N; Hubbard JL; Piccart M; Gianni L; Rowinsky EK
    J Clin Oncol; 1993 May; 11(5):885-90. PubMed ID: 8098057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
    Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
    J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypersensitivity reactions to carboplatin and paclitaxel - our five-years experiences].
    Rezáč A; Jílek P; Rezáčová V; Skapinec P; Sedláková I; Tošner J; Spaček J
    Ceska Gynekol; 2013 Dec; 78(6):514-21. PubMed ID: 24372428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital.
    Schwartz JR; Bandera C; Bradley A; Brard L; Legare R; Granai CO; Dizon DS
    Gynecol Oncol; 2007 Apr; 105(1):81-3. PubMed ID: 17157366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.